Cardiac thrombolysis is a medical intervention aimed at dissolving blood clots within the coronary arteries, which are vital vessels supplying the heart muscle with oxygen and nutrients. This procedure is commonly employed in the management of acute myocardial infarction, also known as a heart attack. During a heart attack, a blood clot can obstruct blood flow to a part of the heart, leading to tissue damage and potentially life-threatening complications. Cardiac thrombolysis involves the administration of thrombolytic agents, or clot-busting drugs, to break down the clot and restore blood flow to the affected area of the heart. This timely intervention is crucial in minimizing myocardial damage and improving the chances of a positive outcome. While cardiac thrombolysis has proven effective in certain cases, it is not suitable for all patients, and individual factors such as the time elapsed since the onset of symptoms and the patient's overall health must be carefully considered by healthcare professionals before deciding on this treatment approach.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain